Effects of ACEI and ARB on COVID-19 patients: A meta-analysis

BACKGROUND: The clinical use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB) in patients with COVID-19 infection remains controversial. Therefore, we performed a meta-analysis on the effects of ACEI/ARB on disease symptoms and laboratory tests in hypertensi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Renin Angiotensin Aldosterone Syst
Autors principals: Xue, Yang, Sun, Shaoqing, Cai, Jianing, Zeng, Linwen, Wang, Shihui, Wang, Suhuai, Li, Jingjie, Sun, Lin, Huo, Jianmin
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
COVID-19 and the Renin-Angiotensin-Aldosterone System
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747108/
https://ncbi.nlm.nih.gov/pubmed/33325306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1470320320981321
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars